Class of 2024
For celebrated contributions to improving patient care through his development of innovative biostatistical methodologies including the Quality-adjusted Time Without Symptoms of disease and Toxicity of treatment (Q-TWiST) and Subpopulation Treatment Effect Pattern Plot (STEPP) methods that have had a profound impact on treatment efficacy and patient outcomes, and his leadership of biostatistical collaborations on practice-changing clinical trials in breast cancer, pediatric leukemia and pediatric AIDS.
*Full-length biography pending